Previous 10 | Next 10 |
Image source: The Motley Fool. Cardiovascular Systems Inc (NASDAQ: CSII) Q4 2020 Earnings Call Aug 4, 2020 , 4:30 p.m. ET Operator Continue reading
Cardiovascular Systems, Inc. (CSII) Q4 2020 Earnings Conference Call August 4, 2020 4:30 AM ET Company Participants Jack Nielsen – Vice President Investor Relations and Corporate Communications Scott Ward – Chairman, President, and Chief Executive Officer Jeff Point...
Cardiovascular Systems (NASDAQ: CSII ) : Q4 GAAP EPS of -$0.43 beats by $0.01 . More news on: Cardiovascular Systems, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Conference Call Scheduled for Today, August 4, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $42.5 million decreased 37.6% from fourth quarter last year Net loss was $15.2 million, or $0.43 per basic and diluted share Fiscal year 2020 revenues declined 4.6% to $236.5 mil...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the results from its REACH PVI study were presented a...
Live Webcast at 3:30 p.m. CT (4:30 p.m. ET) Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will host a live webcast of its fiscal 2020 fourth-quarter conference call on Tuesday, August 4, 2020, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fis...
Shares of cardiovascular-health company Shockwave Medical (NASDAQ: SWAV) fell on Thursday after the Patent Trial and Appeal Board ruled that two of its patents are invalid. The stock ended the day 6% lower. But it had dropped 11% earlier in the day. Shockwave has been issued 40 U.S. patents...
Shockwave Medical (NASDAQ: SWAV ) receives initial rulings related to two of the inter partes review cases initiated by Cardiovascular Systems (NASDAQ: CSII ) in December 2018, challenging the validity of three of Shockwave’s issued patents. More news on: ShockWave Med...
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the underwriters of its recent public offering of common stock ...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that Chairman, President and Chief Executive Officer, Scot...
News, Short Squeeze, Breakout and More Instantly...
Cardiovascular Systems Inc. Company Name:
CSII Stock Symbol:
NASDAQ Market:
Cardiovascular Systems Inc. Website:
Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...
Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...